Literature DB >> 20499000

[Early rheumatoid arthritis: concepts].

Licia Maria Henrique da Mota1, Ieda Maria Magalhães Laurindo, Leopoldo Luiz dos Santos Neto.   

Abstract

Generalization of the concept of early rheumatoid arthritis -RA and existence of a window of therapeutic opportunity, the period when appropriate therapy for this disease would determine clinical improvement, led to the concept that early diagnosis and treatment can change the disease's course. Currently, the goal is to evaluate patients with joint symptoms at the earliest opportunity. Definition of the initial phase of RA includes the first few weeks or months of symptoms (usually less than 12 months), and the first 12 weeks of symptoms of very early or initial RA are considered to be the critical period. Although all patients require early assessment and treatment, there are specific reasons for the involvement of a specialist soon in the evaluation of patients with early RA, since the inflammation that characterizes the disease should be treated as soon as possible. Failure to diagnose or treat a patient with RA at the very early stage of the disease increases the risk of progression to persistent joint inflammation and damage. On the other hand, aggressively treating patients with mild arthritis, which probably will not evolve to erosive forms is equally damaging. It exposes patients to risk without proven benefits and represents the opposite of effective early treatment. Therefore, within the current concept of a window of opportunity, early diagnosis of RA is essential and to establish, as soon as possible those patients who will progress to more severe forms, and therefore require more aggressive therapy.

Entities:  

Mesh:

Year:  2010        PMID: 20499000     DOI: 10.1590/s0104-42302010000200024

Source DB:  PubMed          Journal:  Rev Assoc Med Bras (1992)        ISSN: 0104-4230            Impact factor:   1.209


  4 in total

1.  Antibodies to citrullinated peptides in tuberculosis.

Authors:  I Lima; R C Oliveira; A Atta; S Marchi; L Barbosa; E Reis; M G Reis; M B Santiago
Journal:  Clin Rheumatol       Date:  2013-01-24       Impact factor: 2.980

Review 2.  HTLV-1, Immune Response and Autoimmunity.

Authors:  Juarez A S Quaresma; Gilberto T Yoshikawa; Roberta V L Koyama; George A S Dias; Satomi Fujihara; Hellen T Fuzii
Journal:  Viruses       Date:  2015-12-24       Impact factor: 5.048

Review 3.  Window of opportunity in rheumatoid arthritis - definitions and supporting evidence: from old to new perspectives.

Authors:  Leonie E Burgers; Karim Raza; Annette H van der Helm-van Mil
Journal:  RMD Open       Date:  2019-04-03

4.  Segmental vitiligo after infliximab use for rheumatoid arthritis--a case report.

Authors:  Clarissa Luiza Dalla Bernardina Carvalho; Luciena Cegatto Martins Ortigosa
Journal:  An Bras Dermatol       Date:  2014 Jan-Feb       Impact factor: 1.896

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.